News

Annexin 3, also known as Anxa 3, would be used to provide better identification of patients with a high probability of prostate cancer, thereby reducing the number of

It is reported that the integration of Acambis’s activities strengthens Sanofi Pasteur’s vaccine pipeline of vaccines in development to better answer global health needs. Acambis’s existing manufacturing capabilities

After serving with the company for almost seven years, Dr Pinto will retire from his current position as CEO. He has agreed to remain associated with Pharming and

The company said that it will use the proceeds to continue development of its high potential projects: the commercialization in France and abroad of its first marketable product,

Based in the Alsace BioValley in Strasbourg, the consortium will utilize the pico-liter volumes and ultra-high speed capabilities of RainDance’s technology and systems to achieve breakthrough performance in

The company has appointed Timothy Wentworth as the new group president of employer accounts. Formerly president and CEO of Accredo Health Group, Mr Wentworth will now lead Medco’s

The patent, method for measuring oxidized LDL-CRP complex and measurement kit, describes the binding of oxidized low-density lipoprotein (oxLDL) with C-reactive protein (CRP) resulting in oxLDL/CRP (CRP-AtherOx) complex

QPI-1007, which is currently being evaluated in advanced IND enabling preclinical studies as a neuroprotective agent for eye diseases, is the first drug candidate to utilize a novel

The GT LightTouch technology systematically and rapidly scans the cervix to identify cancers and pre-cancers painlessly and non-invasively by analyzing the wavelengths of light reflected from cervical tissue,